Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EW vs GSK✓SelectedUSD · GSKEW vs GSK performance historyLatest closeAs of-0.19%11/18
Stock and ETF performance explorer

EW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-10.1%
GSK return
+42.7%
Excess return
-52.7%
Maximum drawdown
-54.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-1.3%+1.2%+0.1%
7D-0.5%-3.1%+2.6%+0.1%
30D+20.6%-0.9%+21.5%+20.8%
3M+15.7%-4.2%+19.8%+16.6%
6M+27.7%-1.6%+29.3%+27.7%
YTD+23.4%+2.6%+20.8%+21.8%
1Y+25.2%+6.2%+19.0%+22.6%
3Y+57.3%+55.0%+2.3%+38.5%
5Y-10.1%+42.8%-52.9%-25.7%
All-10.1%+42.7%-52.7%-25.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling